-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Revelation Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
- Revelation Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.52M, a 30.5% decline year-over-year.
- Revelation Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$9.53M, a 59.6% decline year-over-year.
- Revelation Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$8.66M, a 20.3% increase from 2022.
- Revelation Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$10.9M, a 9.09% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)